QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 brookline-capital-initiates-coverage-on-ibio-with-buy-rating-announces-price-target-of-36

Brookline Capital analyst Kemp Dolliver initiates coverage on iBio (AMEX:IBIO) with a Buy rating and announces Price Target ...

 ibio-receives-notice-of-allowance-for-us-patent-application-17821295-titled-anti-cd-25-antibody-for-the-treatment-of-cancer

https://patentcenter.uspto.gov/applications/17821295/ifw/docs

 chardan-capital-maintains-buy-on-ibio-maintains-5-price-target

Chardan Capital analyst Keay Nakae maintains iBio (AMEX:IBIO) with a Buy and maintains $5 price target.

 chardan-capital-initiates-coverage-on-ibio-with-buy-rating-announces-price-target-of-5

Chardan Capital analyst Keay Nakae initiates coverage on iBio (AMEX:IBIO) with a Buy rating and announces Price Target of $5.

 ibio-q3-eps-071-up-from-953-yoy

iBio (AMEX:IBIO) reported quarterly losses of $(0.71) per share. This is a 92.55 percent increase over losses of $(9.53) per sh...

 ibio-files-prospectus-relates-to-resale-from-time-to-time-of-up-to-106m-shares-of-common-stock-by-selling-stockholders

-SEC Filing

 micro-cap-stock-ibio-doubles-on-wednesday---heres-why

iBio surged after collaborating with AstralBio Inc. to develop antibodies for obesity & cardiometabolic conditions. Shares ...

Core News & Articles
Market-Moving News for March 27th
03/27/2024 12:31:22

IBIO: 119% | IBio shares are trading higher after the company collaborated with AstralBio for AI drug-powered antibodies for ob...

 ibio-and-astralbio-announce-transformative-ai-drug-discovery-collaboration-to-rapidly-develop-novel-antibodies-for-obesity-and-cardiometabolic-diseases

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company") announces today that it has entered into a collaboration agre...

 reported-earlier-ibio-raises-15m-in-equity-financing-shares-set-at-285-each

iBio, Inc.  an AI-driven innovator of precision antibody immunotherapies, announces today that it has entered into a securities...

 top-4-health-care-stocks-that-may-rocket-higher-in-q1

The most oversold stocks in the health care presents an opportunity to buy into undervalued companies.

 crude-oil-moves-lower-autozone-profit-tops-views

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher on Tuesday. The Dow traded down 0...

 why-daktronics-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.

 dow-falls-100-points-ism-services-pmi-increases-in-november

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Tuesday. The Dow traded...

 us-stocks-down-jm-smucker-posts-upbeat-earnings

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 50 points on Tuesday. Following the market openi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION